A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma

Background. Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with rapid tumor progression and poor prognosis. This study was motivated by the lack of sensitive and specific PDAC biomarkers and aimed to identify a diagnostic, serum protein signature for PDAC. Methods. To mimic a real...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Proteomics
Autores principales: Gerdtsson, Anna S., Malats, Núria, Säll, Anna, Real, Francisco X., Porta, Miquel, Skoog, Petter, Persson, Helena, Wingren, Christer, Borrebaeck, Carl A. K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4637476/
https://ncbi.nlm.nih.gov/pubmed/26587286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/587250
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares